5 June 2018
First Minister Nicola Sturgeon visited EnteroBiotix in Aberdeen – a life sciences startup developing medicinal products for patients suffering from diseases related to bacteria imbalances in the intestinal tract.
FM @NicolaSturgeon and CMO @CathCalderwood1 visited @EnteroBiotix in Aberdeen to see their pioneering work and research to transform the treatment of C-difficile and other conditions. pic.twitter.com/Lz8dXZ9z0l
— First Minister (@ScotGovFM) June 4, 2018
The company announced they will now be working with NHS Tayside and Tayside Academic Health Science Network to do further research to transform the treatment of C-difficile and other conditions.
The First Minister was joined by the Chief Medical Officer Catherine Calderwood.
Today we welcomed the First Minister and the Chief Medical Officer to our facilities as we announced a major NHS partnership https://t.co/Dx4U1pr9JA
— EnteroBiotix (@EnteroBiotix) June 4, 2018
The First Minister said:
Scotland has a thriving life sciences sector that is renowned globally for innovation and its contribution to pioneering treatments for patients with serious medical conditions. Scottish companies like EnteroBiotix are testament to this.
“The research undertaken at this new facility will have a massive impact on future medical treatments for patients both here in Scotland and further afield.
“The Scottish Government recognises the importance of creating the right environment to allow innovative companies, such as EnteroBiotix, to prosper and I’m pleased the Scottish Government, through Scottish Enterprise, has provided the support for them to grow.”